Pancreatic Development and Regeneration: Toward Cellular Therapies for Diabetes (R01)
The summary for the Pancreatic Development and Regeneration: Toward Cellular Therapies for Diabetes (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pancreatic Development and Regeneration: Toward Cellular Therapies for Diabetes (R01): -The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications to understand how endogenous pancreatic beta cells are made by studying pancreatic development, with the goal of making pancreatic islets in culture, to explore the potential of animal or human stem/progenitor cells (embryonic or adult; if human embryonic, only NIH approved human embryonic stem cell lines may be used) as a source for making pancreatic islets, and to determine the basic mechanisms underlying beta cell regeneration in the adult as a basis for producing new cellular therapies for diabetes. This PA is intended to stimulate the application of advances made in developmental biology, stem cell biology, and diabetes to develop new strategies for diabetes therapy, either through cell replacement or regeneration. This PA is intended to intensify investigator-initiated research, to attract new investigators to the field, and to encourage interdisciplinary approaches to research in this area. -Eligible organizations include for profit and non-profit organizations, including public or private institutions, units of state and local governments, eligible agencies of the federal government, domestic or foreign institutions/organizations, and faith-based or community-based organizations. -Eligible principal investigators include any individual with the skill, knowledge and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. -Applicants may submit more than one application, provided they are scientifically distinct.
|Federal Grant Title:||Pancreatic Development and Regeneration: Toward Cellular Therapies for Diabetes (R01)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-06-271|
|Type of Funding:||Grant|
|CFDA Descriptions:||Diabetes, Endocrinology and Metabolism Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple Receipt Dates - See Link to Full Announce|
|Posted Date:||Mar 24, 2006|
|Creation Date:||Nov 21, 2006|
|Archive Date:||Feb 03, 2007|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Public housing authorities/Indian housing authorities City or township governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Independent school districts Private institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Special district governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Similar Government Grants
- • Understanding the Functional Contributions and Mechanisms of Type 2 Diabetes Disease-assoc...
- • Limited Competition for the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes Kn...
- • NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed)
- • Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Me...
- • Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Met...
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Pilot and Feasibility Program in Human Islet Biology
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...